SIGA | SIGA Technologies, Inc. Stock Overview

(Stock Exchange: NASDAQ)

Day's Range	7.83 - 8.17
52 Week Range	4.26 - 12.83
Beta	0.89
Implied Volatility	60.74%
IV Rank	17.63%
Day's Volume	605,358
Average Volume	1,423,022
Shares Outstanding	71,369,300
Market Cap	568,813,321
Sector	Healthcare
Industry	Drug Manufacturers - Specialty & Generic
IPO Date	1997-09-10

Valuation
Profitability
Growth
Health
P/E Ratio	6.81
Forward P/E Ratio	4.21
EPS	1.17
1YR Price Target	N/A
Dividend Yield	5.71%
Dividend Per Share	0.46
Dividend ExDate	N/A
Dividend PayDate	N/A
Employees	45
Country	USA
Website	SIGA

SIGA Technologies Inc is a commercial-stage pharmaceutical company focused on the health security market. The company's lead product is TPOXX, an orally administered antiviral drug for the treatment of human smallpox disease caused by the variola virus. Its products target orthopoxvirus infections including smallpox.

SIGA's peers: ELAN, ESPR, INVVY, CTLT, CPHI, HCANF, ALIM, SXTC, PTPI, SHPH, MNK, ORGO, LSDI, PCRX, PAHC, RDY, COLL, SSIC, NBIX, DCPH, IRWD, ALKS, AVDL, TAK, HLN

*Chart delayed

Analyzing fundamentals for SIGA we got that it has strong fundamentals where Valuation is considered to be significantly undervalued, Profitability is stunning wealthy, Growth is exceptionally good and Health is confidently strong. For more detailed analysis please see SIGA Fundamentals page.

Watching at SIGA technicals we can see that long-term trend is bullish, while middle-term trend is bearish, as well as bearish short-term trend. More technicals details can be found on SIGA Technicals page.